{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:22:19Z","timestamp":1792239739714,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000182","name":"Medical Research and Materiel Command","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021054","name":"Military Operational Medicine Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsams.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Science and Medicine in Sport"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jsams.2024.02.002","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T04:10:29Z","timestamp":1707797429000},"page":"287-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["NSAIDs do not prevent exercise-induced performance deficits or alleviate muscle soreness: A placebo-controlled randomized, double-blinded, cross-over study"],"prefix":"10.1016","volume":"27","author":[{"given":"Brandon M.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara E.","family":"Sczuroski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Zeppetelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel I.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent P.","family":"Pecorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess A.","family":"Gwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery S.","family":"Staab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsams.2024.02.002_bb0005","first-page":"197","article-title":"Treatment and prevention of delayed onset muscle soreness","volume":"17","author":"Connolly","year":"2003","journal-title":"J Strength Cond Res"},{"issue":"11","key":"10.1016\/j.jsams.2024.02.002_bb0010","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1111\/sms.13275","article-title":"Analgesic and anti-inflammatory drugs in sports: implications for exercise performance and training adaptations","volume":"28","author":"Lundberg","year":"2018","journal-title":"Scand J Med Sci Sports"},{"issue":"1","key":"10.1016\/j.jsams.2024.02.002_bb0015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/s12891-020-03581-y","article-title":"Epidemiological profile of pain and non-steroid anti-inflammatory drug use in collegiate athletes in the United States","volume":"21","author":"Christopher","year":"2020","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"10.1016\/j.jsams.2024.02.002_bb0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1519\/JSC.0b013e318291ba98","article-title":"Use of analgesics for exercise-associated pain: prevalence and predictors of use in recreationally trained college-aged students","volume":"28","author":"Brewer","year":"2014","journal-title":"J Strength Cond Res"},{"issue":"1","key":"10.1016\/j.jsams.2024.02.002_bb0025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3810\/psm.2010.04.1770","article-title":"Prophylactic use of NSAIDs by athletes: a risk\/benefit assessment","volume":"38","author":"Warden","year":"2010","journal-title":"Phys Sportsmed"},{"issue":"4","key":"10.1016\/j.jsams.2024.02.002_bb0030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.rehab.2010.03.001","article-title":"Non-steroidal anti-inflammatory drugs for athletes: an update","volume":"53","author":"Ziltener","year":"2010","journal-title":"Ann Phys Rehabil Med"},{"issue":"3","key":"10.1016\/j.jsams.2024.02.002_bb0035","doi-asserted-by":"crossref","first-page":"e1709","DOI":"10.7205\/MILMED-D-16-00183","article-title":"Widespread use of prescription nonsteroidal anti-inflammatory drugs among U.S. Army active duty soldiers","volume":"182","author":"Walker","year":"2017","journal-title":"Mil Med"},{"issue":"5","key":"10.1016\/j.jsams.2024.02.002_bb0040","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9343(98)00091-6","article-title":"Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs","volume":"104","author":"Cryer","year":"1998","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.jsams.2024.02.002_bb0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.jsams.2024.02.002_bb0050","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/japplphysiol.00061.2013","article-title":"Effects of prostaglandins and COX-inhibiting drugs on skeletal muscle adaptations to exercise","volume":"115","author":"Trappe","year":"2013","journal-title":"J Appl Physiol (1985)"},{"issue":"7","key":"10.1016\/j.jsams.2024.02.002_bb0055","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/jm0613166","article-title":"Structural and functional basis of cyclooxygenase inhibition","volume":"50","author":"Blobaum","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.jsams.2024.02.002_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.exger.2018.10.011","article-title":"Impact of drugs with anti-inflammatory effects on skeletal muscle and inflammation: a systematic literature review","volume":"114","author":"Alturki","year":"2018","journal-title":"Exp Gerontol"},{"issue":"12","key":"10.1016\/j.jsams.2024.02.002_bb0065","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/BF03262309","article-title":"The use of nonsteroidal anti-inflammatory drugs for exercise-induced muscle damage: implications for skeletal muscle development","volume":"42","author":"Schoenfeld","year":"2012","journal-title":"Sports Med"},{"issue":"2","key":"10.1016\/j.jsams.2024.02.002_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/apha.12990","article-title":"Non-steroidal anti-inflammatory drugs may blunt more than pain","volume":"222","author":"Schoenfeld","year":"2018","journal-title":"Acta Physiol (Oxf)"},{"issue":"1","key":"10.1016\/j.jsams.2024.02.002_bb0075","doi-asserted-by":"crossref","DOI":"10.1080\/15502783.2024.2302046","article-title":"The dose-response effects of flurbiprofen, indomethacin, ibuprofen, and naproxen on primary skeletal muscle cells","volume":"21","author":"Roberts","year":"2024","journal-title":"J Int Soc Sports Nutr"},{"issue":"21","key":"10.1016\/j.jsams.2024.02.002_bb0080","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15481","article-title":"Celecoxib impairs primary human myoblast proliferation and differentiation independent of cyclooxygenase 2 inhibition","volume":"10","author":"Matheny","year":"2022","journal-title":"Physiol Rep"},{"issue":"3","key":"10.1016\/j.jsams.2024.02.002_bb0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/026404199366091","article-title":"The effect of a prophylactic dose of flurbiprofen on muscle soreness and sprinting performance in trained subjects","volume":"17","author":"Semark","year":"1999","journal-title":"J Sports Sci"},{"issue":"14","key":"10.1016\/j.jsams.2024.02.002_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17145157","article-title":"Effects of ibuprofen intake in muscle damage, body temperature and muscle power in Paralympic powerlifting athletes","volume":"17","author":"Fraga","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.jsams.2024.02.002_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1249\/00005768-199301000-00003","article-title":"Effect of ibuprofen use on muscle soreness, damage, and performance: a preliminary investigation","volume":"25","author":"Hasson","year":"1993","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"10.1016\/j.jsams.2024.02.002_bb0100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/0363546517697957","article-title":"Effect of NSAIDs on recovery from acute skeletal muscle injury: a systematic review and meta-analysis","volume":"46","author":"Morelli","year":"2018","journal-title":"Am J Sports Med"},{"issue":"1","key":"10.1016\/j.jsams.2024.02.002_bb0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40798-020-00247-w","article-title":"Effect of non-steroidal anti-inflammatory drugs on sport performance indices in healthy people: a meta-analysis of randomized controlled trials","volume":"6","author":"Cornu","year":"2020","journal-title":"Sports Med Open"},{"issue":"10","key":"10.1016\/j.jsams.2024.02.002_bb0110","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13695","article-title":"Circulating sclerostin is not suppressed following a single bout of exercise in young men","volume":"6","author":"Guerriere","year":"2018","journal-title":"Physiol Rep"},{"issue":"10","key":"10.1016\/j.jsams.2024.02.002_bb0115","doi-asserted-by":"crossref","first-page":"R1080","DOI":"10.1152\/ajpregu.00275.2012","article-title":"IGF-I measurement across blood, interstitial fluid, and muscle biocompartments following explosive, high-power exercise","volume":"303","author":"Nindl","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"10.1016\/j.jsams.2024.02.002_bb0120","first-page":"60","article-title":"Maximum based on reps","volume":"6","author":"Landers","year":"1984","journal-title":"NSCA J"},{"issue":"1","key":"10.1016\/j.jsams.2024.02.002_bb0125","doi-asserted-by":"crossref","DOI":"10.1080\/15502783.2022.2164209","article-title":"The dose-response effects of arachidonic acid on primary human skeletal myoblasts and myotubes","volume":"20","author":"Roberts","year":"2023","journal-title":"J Int Soc Sports Nutr"},{"key":"10.1016\/j.jsams.2024.02.002_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jare.2018.03.005","article-title":"Synopsis of arachidonic acid metabolism: a review","volume":"11","author":"Hanna","year":"2018","journal-title":"J Adv Res"},{"issue":"11","key":"10.1016\/j.jsams.2024.02.002_bb0135","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI13210","article-title":"Arachidonic acid as a bioactive molecule","volume":"107","author":"Brash","year":"2001","journal-title":"J Clin Invest"},{"issue":"6\u20138","key":"10.1016\/j.jsams.2024.02.002_bb0140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10974-008-9154-9","article-title":"Prostaglandins in muscle regeneration","volume":"29","author":"Velica","year":"2008","journal-title":"J Muscle Res Cell Motil"},{"issue":"1","key":"10.1016\/j.jsams.2024.02.002_bb0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bcpt.12117","article-title":"Variability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectives","volume":"114","author":"Bruno","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.jsams.2024.02.002_bb0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/bjsm.24.3.191","article-title":"Effects of ibuprofen on exercise-induced muscle soreness and indices of muscle damage","volume":"24","author":"Donnelly","year":"1990","journal-title":"Br J Sports Med"},{"issue":"3","key":"10.1016\/j.jsams.2024.02.002_bb0155","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1139\/H08-019","article-title":"The effects of ibuprofen on muscle hypertrophy, strength, and soreness during resistance training","volume":"33","author":"Krentz","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"issue":"6","key":"10.1016\/j.jsams.2024.02.002_bb0160","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00042752-200211000-00009","article-title":"Preliminary comparison of bromelain and ibuprofen for delayed onset muscle soreness management","volume":"12","author":"Stone","year":"2002","journal-title":"Clin J Sport Med"},{"issue":"8","key":"10.1016\/j.jsams.2024.02.002_bb0165","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/02640410400021989","article-title":"The isolated and combined effects of selected physical activity and ibuprofen on delayed-onset muscle soreness","volume":"23","author":"Rahnama","year":"2005","journal-title":"J Sports Sci"},{"issue":"1","key":"10.1016\/j.jsams.2024.02.002_bb0170","first-page":"53","article-title":"The effects of ibuprofen on delayed muscle soreness and muscular performance after eccentric exercise","volume":"17","author":"Tokmakidis","year":"2003","journal-title":"J Strength Cond Res"},{"issue":"7","key":"10.1016\/j.jsams.2024.02.002_bb0175","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1519\/JSC.0000000000002502","article-title":"Effect of ibuprofen on muscle, hematological and renal function, hydric balance, pain, and performance during intense long-distance running","volume":"34","author":"de Souza","year":"2020","journal-title":"J Strength Cond Res"},{"key":"10.1016\/j.jsams.2024.02.002_bb0180","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3389\/fphys.2017.01074","article-title":"Resistance training with co-ingestion of anti-inflammatory drugs attenuates mitochondrial function","volume":"8","author":"Cardinale","year":"2017","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.jsams.2024.02.002_bb0185","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1111\/j.1600-0838.2009.00947.x","article-title":"A COX-2 inhibitor reduces muscle soreness, but does not influence recovery and adaptation after eccentric exercise","volume":"20","author":"Paulsen","year":"2010","journal-title":"Scand J Med Sci Sports"},{"issue":"2","key":"10.1016\/j.jsams.2024.02.002_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/apha.12948","article-title":"High doses of anti-inflammatory drugs compromise muscle strength and hypertrophic adaptations to resistance training in young adults","volume":"222","author":"Lilja","year":"2018","journal-title":"Acta Physiol (Oxf)"}],"container-title":["Journal of Science and Medicine in Sport"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1440244024000501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1440244024000501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T18:22:26Z","timestamp":1716229346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1440244024000501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1440244024000501"],"URL":"https:\/\/doi.org\/10.1016\/j.jsams.2024.02.002","relation":{},"ISSN":["1440-2440"],"issn-type":[{"value":"1440-2440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NSAIDs do not prevent exercise-induced performance deficits or alleviate muscle soreness: A placebo-controlled randomized, double-blinded, cross-over study","name":"articletitle","label":"Article Title"},{"value":"Journal of Science and Medicine in Sport","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsams.2024.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of Sports Medicine Australia.","name":"copyright","label":"Copyright"}]}}